PharmaMar Shares Soar After Drug Study Suggests Efficacy Against Omicron
Shares in PharmaMar jumped almost 20% on Tuesday after the Spanish drugmaker said lab trials suggested its Plitidepsin drug was effective against the main COVID-19 variants, including the highly contagious Omicron.
Reuters Health Information
source https://www.medscape.com/viewarticle/966392?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/966392?src=rss
Comments
Post a Comment